
	March 31, 2025						December 31, 2024						March 31, 2024
(In millions)	Current		Non-current		Total		Current		Non-current		Total		Total
Unpaid claims and claim expenses
Cigna Healthcare	$	4,452	$	56	$	4,508	$	4,932	$	86	$	5,018	$	5,863
Other	172		194		366		147		144		291		260
Future policy benefits
Cigna Healthcare	38		154		192		91		507		598		607
Other Operations	151		3,157		3,308		157		3,140		3,297		3,460
Contractholder deposit funds
Cigna Healthcare	—		—		—		9		115		124		141
Other Operations	348		5,903		6,251		366		5,958		6,324		6,452
Market risk benefits	30		800		830		25		760		785		891
Unearned premiums	793		45		838		753		31		784		836
Total							6,480		10,741		17,221		18,510
Insurance and contractholder liabilities classified as liabilities of businesses held for sale (1)							(1,092)		(487)		(1,579)		(2,081)
Total insurance and contractholder liabilities	$	5,984	$	10,309	$	16,293	$	5,388	$	10,254	$	15,642	$	16,429

(1) Amounts classified as liabilities of businesses held for sale include $983 million of Unpaid claims, $408 million of Future policy benefits, $85 million of Unearned premiums and $103 million of Contractholder deposit funds as of December 31, 2024 and $1,378 million of Unpaid claims, $427 million of Future policy benefits, $161 million of Unearned premiums and $115 million of Contractholder deposit funds as of March 31, 2024.

This liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, expected development on reported claims, claims that have been reported but not yet paid (reported claims in process), and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.

The total of incurred but not reported liabilities plus expected development on reported claims and reported claims in process was $4.4 billion at March 31, 2025 and $5.4 billion at March 31, 2024. The decrease was driven by the HCSC transaction.


	Three Months Ended March 31,
(In millions)	2025 (1)		2024 (1)
Beginning balance	$	5,018	$	5,092
Less: Reinsurance and other amounts recoverable	159		236
Beginning balance, net	4,859		4,856

Incurred costs related to:
Current year	10,606		9,452
Prior years	(222)		(226)
Total incurred	10,384		9,226
Paid costs related to:
Current year	6,078		5,072
Prior years	3,472		3,352
Total paid	9,550		8,424
Less: Divestiture and other	1,323		—
Ending balance, net	4,370		5,658
Add: Reinsurance and other amounts recoverable	138		205
Ending balance	$	4,508	$	5,863

(1) Includes unpaid claims amounts classified as liabilities of businesses held for sale prior to the completion of the HCSC transaction. As of December 31, 2024, March 31, 2024 and December 31, 2023, includes $983 million and $1,378 million, $823 million classified as liabilities of businesses held for sale, respectively.

Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsurance.


	Three Months Ended March 31,
	2025				2024
(Dollars in millions)	$		% (1)		$		% (2)
Actual completion factors and other	$	96	0.3	%	$	76	0.2	%
Medical cost trend	126		0.3		150		0.4

Total favorable variance	$	222	0.6	%	$	226	0.6	%

Future policy benefits for the Cigna Healthcare segment were primarily related to the businesses divested to HCSC on March 19, 2025. Excluding the divestiture, changes in the future policy benefits for the three months ended March 31, 2025 and March 31, 2024 were not material.

Obligations for annuities represent discounted periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Other Operations' traditional insurance contracts, which are in run-off, have no premium remaining to be collected; therefore, future policy benefit reserves represent the present value of expected future policy benefits, discounted using the current discount rate, and the remaining amortizable deferred profit liability.

Future policy benefits for Other Operations includes deferred profit liability of $359 million as of March 31, 2025 and $379 million as of March 31, 2024. Future policy benefits excluding deferred profit liability were $3.0 billion as of March 31, 2025, $3.1 billion as of March 31, 2024, $2.9 billion as of December 31, 2024, and $3.2 billion as of December 31, 2023. Undiscounted expected future policy benefits were $4.3 billion as of March 31, 2025 and $4.4 billion as of March 31, 2024. As of March 31, 2025 and March 31, 2024, $0.9 billion and $1.0 billion, respectively, of the future policy benefit reserve was recoverable through treaties with external reinsurers.

Contractholder deposit fund liabilities within Other Operations were $6.3 billion as of both as of March 31, 2025 and December 31, 2024 and $6.5 billion as of both March 31, 2024 and December 31, 2023. Approximately 38% of the balance is reinsured externally. Activity in these liabilities is presented net of reinsurance in the Consolidated Statements of Cash Flows. Changes in contractholder deposit fund liabilities generally relates to withdrawals and benefit payments, partially offset by deposits and interest credited.

As of March 31, 2025, the weighted average crediting rate, net amount at risk and cash surrender value for contractholder deposit fund liabilities not effectively exited through reinsurance were 3.20%, $2.8 billion and $2.8 billion, respectively. The comparative amounts as of March 31, 2024 were 3.33%, $3.0 billion and $2.8 billion, respectively. More than 99% of the $4.0 billion liability as of both March 31, 2025 and March 31, 2024 not reinsured externally is for contracts with guaranteed interest rates of 3% - 4%, and approximately $1.2 billion as of both March 31, 2025 and March 31, 2024 represented contracts with policies at the guarantee. As of both March 31, 2025 and March 31, 2024, $1.2 billion was 50-150 basis points ("bps") above the guarantee and the remaining $1.6 billion represented contracts above the guarantee that pay the policyholder based on the greater of a guaranteed minimum cash value or the actual cash value. As of both March 31, 2025 and March 31, 2024, more than 90% of these contracts have actual cash values of at least 110% of the guaranteed cash value.

Liabilities for market risk benefits ("MRBs") consist of variable annuity reinsurance contracts in Other Operations. These liabilities arise under annuities and riders to annuities written by ceding companies that guarantee the benefit received at death and, for a subset of policies, also provide contractholders the option, within 30 days of a policy anniversary after the appropriate waiting period, to elect minimum income payments. The Company's capital market risk exposure on variable annuity reinsurance contracts arises when the reinsured guaranteed minimum benefit exceeds the contractholder's account value in the related underlying mutual funds at the time the insurance benefit is payable under the respective contract. The Company receives and pays premium periodically based on the terms of the reinsurance agreements.

Market risk benefits activity was as follows:


	Three Months Ended March 31,
(In millions)	2025		2024
Balance, beginning of year	$	785	$	1,003
Balance, beginning of year, before the effect of nonperformance risk (own credit risk)	838		1,085
Changes due to expected run-off	(4)		(3)
Changes due to capital markets versus expected	44		(113)
Changes due to policyholder behavior versus expected	—		(14)

Balance, end of period, before the effect of changes in nonperformance risk (own credit risk)	878		955
Nonperformance risk (own credit risk), end of period	(48)		(64)
Balance, end of period	$	830	$	891
Reinsured market risk benefit, end of period	$	876	$	951

The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.